West Pharmaceutical Services WST
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
West Pharmaceutical Services (WST) Core Market Data and Business Metrics
Latest Closing Price
$221.5Price-Earnings Ratio
33.11Total Outstanding Shares
72.29 Million SharesDividend
$0.21 Per Share QuarterlySIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
New York Stock ExchangeHeadquarters
530 Herman O. West Drive, Exton, PA, 19341
Historical Stock Splits
If you bought 1 share of WST before September 27, 2013, you'd have 2 shares today.
| Execution Date | Split Amount |
|---|---|
| September 27, 2013 | 2-for-1 |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 1,001,082 Shares | 1.54 | 3/14/2025 | 1,540,781 Shares |
| 1,695,381 Shares | 1 | 2/28/2025 | 1,369,698 Shares |
| 1,435,712 Shares | 1 | 2/14/2025 | 1,193,392 Shares |
| 409,512 Shares | 3.28 | 1/31/2025 | 1,343,973 Shares |
| 461,345 Shares | 3.26 | 1/15/2025 | 1,502,467 Shares |
| 605,787 Shares | 2.47 | 12/31/2024 | 1,495,605 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities, Continuing | $653.40 Million |
| Net Cash Flow From Investing Activities | $-378.70 Million |
| Net Cash Flow From Investing Activities, Continuing | $-378.70 Million |
| Net Cash Flow From Financing Activities, Continuing | $-622.60 Million |
| Net Cash Flow From Financing Activities | $-622.60 Million |
| Net Cash Flow From Operating Activities | $653.40 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Operating Income/Loss | $569.90 Million |
| Gross Profit | $998.50 Million |
| Revenues | $2.89 Billion |
| Diluted Average Shares | $73.70 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $492.70 Million |
| Diluted Earnings Per Share | $6.69 |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss Attributable To Parent | $-114.30 Million |
| Other Comprehensive Income/Loss | $378.40 Million |
| Comprehensive Income/Loss Attributable To Parent | $378.40 Million |
| Comprehensive Income/Loss | $378.40 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Current Liabilities | $550.40 Million |
| Noncurrent Liabilities | $410.70 Million |
| Accounts Payable | $239.30 Million |
| Liabilities And Equity | $3.64 Billion |
| Current Assets | $1.54 Billion |
| Equity Attributable To Parent | $2.68 Billion |
Historical Dividends
Current dividend: $0.21 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 20, 2025 | May 7, 2025 | Apr 30, 2025 | $0.21 | Quarterly |
| Jan 28, 2025 | Feb 11, 2025 | Feb 7, 2025 | $0.21 | Quarterly |
| Oct 24, 2024 | Nov 20, 2024 | Nov 13, 2024 | $0.21 | Quarterly |
| Apr 25, 2024 | Aug 7, 2024 | Jul 31, 2024 | $0.2 | Quarterly |
| Feb 20, 2024 | May 1, 2024 | Apr 24, 2024 | $0.2 | Quarterly |
| Dec 6, 2023 | Feb 7, 2024 | Jan 31, 2024 | $0.2 | Quarterly |